Staff Publications

Staff Publications

  • external user (warningwarning)
  • Log in as
  • language uk
  • About

    'Staff publications' is the digital repository of Wageningen University & Research

    'Staff publications' contains references to publications authored by Wageningen University staff from 1976 onward.

    Publications authored by the staff of the Research Institutes are available from 1995 onwards.

    Full text documents are added when available. The database is updated daily and currently holds about 240,000 items, of which 72,000 in open access.

    We have a manual that explains all the features 

Record number 455321
Title No effect on n-3 fatty acids supplementation on NT-proBNP after myocardial infaction: THe Alpha Omega Trial
Author(s) Hoogeveen, E.K.; Geleijnse, J.M.; Kromhout, D.; Sant, P. van 't; Gemen, E.F.; Giltay, E.J.
Source European Journal of Preventive Cardiology 22 (2015)5. - ISSN 2047-4873 - p. 648 - 655.
DOI https://doi.org/10.1177/2047487314536694
Department(s) Chair Nutrition and Disease
VLAG
Publication type Refereed Article in a scientific journal
Publication year 2015
Keyword(s) brain natriuretic peptide - chronic heart-failure - glomerular-filtration-rate - serum creatinine - cystatin c - stability - risk - omega-3-fatty-acids - metaanalysis - mortality
Abstract BACKGROUND: heart failure is a major risk factor for cardiovascular mortality, for which n-3 fatty acids may have beneficial effects. We examined the effect of marine eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and plant-derived alpha-linolenic acid (ALA) on N-Terminal-pro Brain Natriuretic Peptide (NT-proBNP), a biomarker of heart failure. METHODS: we randomly assigned 4837 post-myocardial infarction patients, aged 60-80 years (82% men), to margarines supplemented with a targeted additional intake of 400¿mg/day EPA and DHA, 2¿g/day ALA, EPA-DHA plus ALA, or placebo for 40 months. In a random selection of 639 patients, NT-proBNP was determined both at baseline and at the end of follow-up. NT-proBNP was loge-transformed and analysed by type of treatment using analysis of covariance adjusting for baseline NT-proNBP. RESULTS: patients consumed on average 19.8¿g margarine/day, providing an additional amount of 238¿mg/day EPA with 158¿mg/day DHA, 1.98¿g/day ALA, or both, in the active-treatment groups. In the placebo group, the geometric mean level NT-proBNP increased from 245¿ng/l (95%-confidence interval [CI]: 207-290) to 294¿ng/l (95%-CI: 244-352) after 40 months (p¿=¿0.001). NT-proBNP levels were not affected by ALA (+8% versus placebo; 95%-CI: -8% to +25%; p¿=¿0.34), EPA-DHA (+2% versus placebo; 95%-CI: -14% to +18%; p¿=¿0.78), nor EPA-DHA plus ALA (+9% versus placebo; 95%-CI: -8% to +25%; p¿=¿0.31) treatment. CONCLUSIONS: supplementation with modest amounts of EPA-DHA, with or without ALA, did not have a significant effect on NT-proBNP levels in patients with a history of myocardial infarction.
Comments
There are no comments yet. You can post the first one!
Post a comment
 
Please log in to use this service. Login as Wageningen University & Research user or guest user in upper right hand corner of this page.